Pyxis One, which offers no-code AI models to companies for targeted marketing, raises a $100M Series C led by SoftBank Vision Fund 2 and renames itself to Pixis
Christine Hall / TechCrunch :
Context & Ripple Effects
Pyxis One's $100M Series C is a SoftBank Vision Fund 2 check at the peak of the fund's deployment cadence — it had put $9.9B to work across 49 deals in Q4 2021 and another $9.9B across 52 deals in Q1 2022, following its earlier Vision Fund-led bet on AI drug-discovery firm XtalPi. The simultaneous rebrand to Pixis signals the company positioning as a platform rather than a single-product vendor.
The arc closes out in the related coverage: eighteen months later Pixis needed an $85M Series C1 from Touring Capital to reach $209M total funding, disclosing $50M ARR — meaning the original $100M round did not carry it to self-sufficiency before growth capital repriced.
First-order effects
- Pixis gains a war chest to scale its no-code targeted-marketing models while shedding the 'Pyxis One' name, and SoftBank Vision Fund 2 adds another application-layer AI company to a portfolio it was building at roughly 50 deals per quarter.
Second-order effects
- Rival marketing-AI vendors now compete against a category peer with nine-figure backing, pushing them toward their own large rounds or differentiated verticals; meanwhile, the fund's collapse to a single investment by August 2022 means founders raising after this round could no longer assume a comparable SoftBank check.
Third-order effects
- The pattern here — a peak-cycle mega-round followed by an extension round and an ARR disclosure once capital tightened — previews how AI application companies would be forced to prove revenue milestones to keep growing, with growth-stage money concentrating in fewer, de-risked names.
The trend: Growth-stage AI capital is cycling from indiscriminate mega-checks at application-layer startups toward ARR-backed follow-ons, with SoftBank's own deal cadence marking the turn.